Aristolochic acid downregulates monocytic matrix metalloproteinase-9 by inhibiting nuclear factor-κB activation

Chih Jen Wu, Yung Chen Chou, Yu Wen Cheng, Che Jen Hsiao, Chen Hsu Wang, Hsin Yu Wang, Joen Rong Sheu, George Hsiao

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Aristolochic acid (AA)-associated nephropathy was described as being characterized by a rapid progressive enhancement of interstitial renal fibrosis. Renal tissue fibrosis occurs because of an imbalance of extracellular matrix (ECM) accumulation and matrix metalloproteinase (MMP) activation. Much evidence indicates that inflammatory renal disease including monocyte and mesangial interactions is linked to the development and progression of renal remodeling. In this study, we found that AA showed concentration-dependent inhibition of tumor necrosis factor (TNF)-α-induced MMP-9 activation with an IC 50 value of 6.4 ± 0.5 μM in human monocytic THP-1 cells. A similar effect was also noted with different ratios of AAs (types I and II). However, AA had no inhibitory effect on the intact enzymatic activity of MMP-9 at a concentration of 20 μM. On the other hand, the level of tissue inhibitor of metalloproteinase (TIMP)-1 was not induced by AA, but it suppressed TNF-α-induced MMP-9 protein and messenger RNA expressions. AA also significantly inhibited TNF-α-induced IκBα degradation. Furthermore, an electrophoretic mobility shift assay and a reported gene study, respectively, revealed that AA inhibited TNF-α-induced NF-κB translocation and activation. In addition, compared to other NF-κB inhibitors, AA exerted significant inhibition of MMP-9 activation and monocyte chemotactic protein-1-directed invasion. From these results, we concluded that AA, a natural compound, inhibits TNF-α-induced MMP-9 in human monocytic cells possibly through the NF-κB signal pathway. These results also imply that AA may be involved in alteration of matrix homeostasis during renal fibrosis in vivo.

Original languageEnglish
Pages (from-to)209-219
Number of pages11
JournalChemico-Biological Interactions
Volume192
Issue number3
DOIs
Publication statusPublished - Jul 15 2011

Fingerprint

Matrix Metalloproteinase 9
Down-Regulation
Chemical activation
Tumor Necrosis Factor-alpha
Kidney
Fibrosis
Tissue Inhibitor of Metalloproteinase-1
aristolochic acid I
Chemokine CCL2
Electrophoretic mobility
Electrophoretic Mobility Shift Assay
Matrix Metalloproteinases
Extracellular Matrix
Monocytes
Signal Transduction
Homeostasis
Assays
Genes
Tissue
Messenger RNA

Keywords

  • Aristolochic acid
  • Matrix metalloproteinase-9
  • Monocytes
  • NF-κB
  • Tumor necrosis factor-α

ASJC Scopus subject areas

  • Toxicology

Cite this

Aristolochic acid downregulates monocytic matrix metalloproteinase-9 by inhibiting nuclear factor-κB activation. / Wu, Chih Jen; Chou, Yung Chen; Cheng, Yu Wen; Hsiao, Che Jen; Wang, Chen Hsu; Wang, Hsin Yu; Sheu, Joen Rong; Hsiao, George.

In: Chemico-Biological Interactions, Vol. 192, No. 3, 15.07.2011, p. 209-219.

Research output: Contribution to journalArticle

@article{8edb76e341334ac79a1ba74806eb2787,
title = "Aristolochic acid downregulates monocytic matrix metalloproteinase-9 by inhibiting nuclear factor-κB activation",
abstract = "Aristolochic acid (AA)-associated nephropathy was described as being characterized by a rapid progressive enhancement of interstitial renal fibrosis. Renal tissue fibrosis occurs because of an imbalance of extracellular matrix (ECM) accumulation and matrix metalloproteinase (MMP) activation. Much evidence indicates that inflammatory renal disease including monocyte and mesangial interactions is linked to the development and progression of renal remodeling. In this study, we found that AA showed concentration-dependent inhibition of tumor necrosis factor (TNF)-α-induced MMP-9 activation with an IC 50 value of 6.4 ± 0.5 μM in human monocytic THP-1 cells. A similar effect was also noted with different ratios of AAs (types I and II). However, AA had no inhibitory effect on the intact enzymatic activity of MMP-9 at a concentration of 20 μM. On the other hand, the level of tissue inhibitor of metalloproteinase (TIMP)-1 was not induced by AA, but it suppressed TNF-α-induced MMP-9 protein and messenger RNA expressions. AA also significantly inhibited TNF-α-induced IκBα degradation. Furthermore, an electrophoretic mobility shift assay and a reported gene study, respectively, revealed that AA inhibited TNF-α-induced NF-κB translocation and activation. In addition, compared to other NF-κB inhibitors, AA exerted significant inhibition of MMP-9 activation and monocyte chemotactic protein-1-directed invasion. From these results, we concluded that AA, a natural compound, inhibits TNF-α-induced MMP-9 in human monocytic cells possibly through the NF-κB signal pathway. These results also imply that AA may be involved in alteration of matrix homeostasis during renal fibrosis in vivo.",
keywords = "Aristolochic acid, Matrix metalloproteinase-9, Monocytes, NF-κB, Tumor necrosis factor-α",
author = "Wu, {Chih Jen} and Chou, {Yung Chen} and Cheng, {Yu Wen} and Hsiao, {Che Jen} and Wang, {Chen Hsu} and Wang, {Hsin Yu} and Sheu, {Joen Rong} and George Hsiao",
year = "2011",
month = "7",
day = "15",
doi = "10.1016/j.cbi.2011.03.012",
language = "English",
volume = "192",
pages = "209--219",
journal = "Chemico-Biological Interactions",
issn = "0009-2797",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Aristolochic acid downregulates monocytic matrix metalloproteinase-9 by inhibiting nuclear factor-κB activation

AU - Wu, Chih Jen

AU - Chou, Yung Chen

AU - Cheng, Yu Wen

AU - Hsiao, Che Jen

AU - Wang, Chen Hsu

AU - Wang, Hsin Yu

AU - Sheu, Joen Rong

AU - Hsiao, George

PY - 2011/7/15

Y1 - 2011/7/15

N2 - Aristolochic acid (AA)-associated nephropathy was described as being characterized by a rapid progressive enhancement of interstitial renal fibrosis. Renal tissue fibrosis occurs because of an imbalance of extracellular matrix (ECM) accumulation and matrix metalloproteinase (MMP) activation. Much evidence indicates that inflammatory renal disease including monocyte and mesangial interactions is linked to the development and progression of renal remodeling. In this study, we found that AA showed concentration-dependent inhibition of tumor necrosis factor (TNF)-α-induced MMP-9 activation with an IC 50 value of 6.4 ± 0.5 μM in human monocytic THP-1 cells. A similar effect was also noted with different ratios of AAs (types I and II). However, AA had no inhibitory effect on the intact enzymatic activity of MMP-9 at a concentration of 20 μM. On the other hand, the level of tissue inhibitor of metalloproteinase (TIMP)-1 was not induced by AA, but it suppressed TNF-α-induced MMP-9 protein and messenger RNA expressions. AA also significantly inhibited TNF-α-induced IκBα degradation. Furthermore, an electrophoretic mobility shift assay and a reported gene study, respectively, revealed that AA inhibited TNF-α-induced NF-κB translocation and activation. In addition, compared to other NF-κB inhibitors, AA exerted significant inhibition of MMP-9 activation and monocyte chemotactic protein-1-directed invasion. From these results, we concluded that AA, a natural compound, inhibits TNF-α-induced MMP-9 in human monocytic cells possibly through the NF-κB signal pathway. These results also imply that AA may be involved in alteration of matrix homeostasis during renal fibrosis in vivo.

AB - Aristolochic acid (AA)-associated nephropathy was described as being characterized by a rapid progressive enhancement of interstitial renal fibrosis. Renal tissue fibrosis occurs because of an imbalance of extracellular matrix (ECM) accumulation and matrix metalloproteinase (MMP) activation. Much evidence indicates that inflammatory renal disease including monocyte and mesangial interactions is linked to the development and progression of renal remodeling. In this study, we found that AA showed concentration-dependent inhibition of tumor necrosis factor (TNF)-α-induced MMP-9 activation with an IC 50 value of 6.4 ± 0.5 μM in human monocytic THP-1 cells. A similar effect was also noted with different ratios of AAs (types I and II). However, AA had no inhibitory effect on the intact enzymatic activity of MMP-9 at a concentration of 20 μM. On the other hand, the level of tissue inhibitor of metalloproteinase (TIMP)-1 was not induced by AA, but it suppressed TNF-α-induced MMP-9 protein and messenger RNA expressions. AA also significantly inhibited TNF-α-induced IκBα degradation. Furthermore, an electrophoretic mobility shift assay and a reported gene study, respectively, revealed that AA inhibited TNF-α-induced NF-κB translocation and activation. In addition, compared to other NF-κB inhibitors, AA exerted significant inhibition of MMP-9 activation and monocyte chemotactic protein-1-directed invasion. From these results, we concluded that AA, a natural compound, inhibits TNF-α-induced MMP-9 in human monocytic cells possibly through the NF-κB signal pathway. These results also imply that AA may be involved in alteration of matrix homeostasis during renal fibrosis in vivo.

KW - Aristolochic acid

KW - Matrix metalloproteinase-9

KW - Monocytes

KW - NF-κB

KW - Tumor necrosis factor-α

UR - http://www.scopus.com/inward/record.url?scp=79957660909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957660909&partnerID=8YFLogxK

U2 - 10.1016/j.cbi.2011.03.012

DO - 10.1016/j.cbi.2011.03.012

M3 - Article

C2 - 21453692

AN - SCOPUS:79957660909

VL - 192

SP - 209

EP - 219

JO - Chemico-Biological Interactions

JF - Chemico-Biological Interactions

SN - 0009-2797

IS - 3

ER -